Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Endocrine
Erschienen in: Endocrine 3/2014

01.04.2014 | Review

Creatine supplementation and aging musculoskeletal health

verfasst von: Darren G. Candow, Philip D. Chilibeck, Scott C. Forbes

Erschienen in: Endocrine | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Sarcopenia refers to the progressive loss of muscle mass and muscle function and is a contributing factor for cachexia, bone loss, and frailty. Resistance training produces several physiological adaptations which improve aging musculoskeletal health, such as increased muscle and bone mass and strength. The combination of creatine supplementation and resistance training may further lead to greater physiological benefits. We performed meta-analyses which indicate creatine supplementation combined with resistance training has a positive effect on aging muscle mass and upper body strength compared to resistance training alone. Creatine also shows promise for improving bone mineral density and indices of bone biology. The combination of creatine supplementation and resistance training could be an effective intervention to improve aging musculoskeletal health.
Literatur
1.
A.J. Cruz-Jentoft, J.P. Baeyens, J.M. Bauer, Y. Boirie, T. Cederholm, F. Landi, F.C. Martin, J.P. Michel, Y. Rolland, S.M. Schneider, E. Topinková, M. Vandewoude, M. Zamboni, European Working Group on Sarcopenia in Older People.: sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39, 412–423 (2010)PubMedCentralPubMedCrossRef
2.
R.A. Fielding, B. Vellas, W.J. Evans, S. Bhasin, J.E. Morley, A.B. Newman, G. Abellan van Kan, S. Andrieu, J. Bauer, D. Breuille, T. Cederholm, J. Chandler, C. De Meynard, L. Donini, T. Harris, A. Kannt, F. Keime Guibert, G. Onder, D. Papanicolaou, Y. Rolland, D. Rooks, C. Sieber, E. Souhami, S. Verlaan, M. Zamboni, Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J. Am. Med. Dir. Assoc. 12, 249–256 (2011)PubMedCrossRef
3.
W.J. Evans, J.E. Morley, J. Argilés, C. Bales, V. Baracos, D. Guttridge, A. Jatoi, K. Kalantar-Zadeh, H. Lochs, G. Mantovani, D. Marks, W.E. Mitch, M. Muscaritoli, A. Najand, P. Ponikowski, F. Rossi Fanelli, M. Schambelan, A. Schols, M. Schuster, D. Thomas, R. Wolfe, S.D. Anker, Cachexia: a new definition. Clin Nutr. 27, 793–799 (2008)PubMedCrossRef
4.
G. Crepaldi, S. Maggi, Sarcopenia and osteoporosis: a hazardous duet. J. Endocrinol. Invest. 28, 66–68 (2005)PubMed
5.
A. Clegg, J. Young, S. Iliffe, M.O. Rikkert, K. Rockwood, Frailty in elderly people. Lancet 2, 752–762 (2013)CrossRef
6.
I. Janssen, D.S. Shepard, P.T. Katzmarzyk, R. Roubenhoff, The healthcare costs of sarcopenia in the United States. J. Am. Geriatr. Soc. 52, 80–85 (2004)PubMedCrossRef
7.
Kohara, K.: Sarcopenia obesity in aging population: current status and future directions for research. Endocrine. Epub ahead of print (2013)
8.
S.C. Forbes, J.P. Little, D.G. Candow, Exercise and nutritional interventions for improving aging muscle health. Endocrine 42, 29–38 (2012)PubMedCrossRef
9.
10.
R. Nilwik, T. Snijders, M. Leenders, B.B. Groen, J. van Kranenburg, L.B. Verdijk, L.J. van Loon, The decline in skeletal muscle mass with aging is mainly attributed to a reduction in type II muscle fiber size. Exp. Gerontol. 48, 492–498 (2013)PubMedCrossRef
11.
L.J. Greenlund, K.S. Nair, Sarcopenia—consequences, mechanisms, and potential therapies. Mech. Ageing Dev. 124, 287–299 (2003)PubMedCrossRef
12.
E. Ziv, D. Hu, Genetic variation in insulin/IGF-1 signaling pathways and longevity. Ageing Res Rev. 10, 201–204 (2011)PubMedCrossRef
13.
A.S. Brack, T.A. Rando, Intrinsic changes and extrinsic influences of myogenic stem cell function during aging. Stem Cell Rev. 3, 226–237 (2007)PubMedCrossRef
14.
A.M. Abbatecola, G. Paolisso, P. Fattoretti, W.J. Evans, V. Fiore, L. Dicioccio, F. Lattanzio, Discovering pathways of sarcopenia in older adults: a role for insulin resistance on mitochondria dysfunction. J. Nutr. Health Aging 15, 890–895 (2011)PubMedCrossRef
15.
E. Marzetti, R. Calvani, R. Bernabei, C. Leeuwenburgh, Apoptosis in skeletal myocytes: a potential target for interventions against sarcopenia and physical frailty—a mini-review. Gerontology 58, 99–106 (2012)PubMedCrossRef
16.
M.A. Tarnopolsky, A. Safdar, The potential benefits of creatine and conjugated linoleic acid as adjuncts to resistance training in older adults. Appl. Physiol. Nutr. Metab. 33, 213–227 (2008)PubMedCrossRef
17.
W.F. Nieuwenhuizen, H. Weenen, P. Rigby, M.M. Hetherington, Older adults and patients in need of nutritional support: review of current treatment options and factors influencing nutritional intake. Clin. Nutr. 29, 160–169 (2010)PubMedCrossRef
18.
M. Wyss, R. Kaddurah-Daouk, Creatine and creatinine metabolism. Physiol. Rev. 80, 1107–1213 (2000)PubMed
19.
R.G. Larsen, D.M. Callahan, S.A. Foulis, J.A. Kent-Braun, Age-related changes in oxidative capacity differ between locomotory muscles and are associated with physical activity behavior. Appl. Physiol. Nutr. Metab. 37, 88–99 (2012)PubMedCentralPubMedCrossRef
20.
K.K. McCully, R.A. Fielding, W.J. Evans, J.S. Leigh Jr, J.D. Posner, Relationships between in vivo and in vitro measurements of metabolism in young and old human calf muscles. J. Appl. Physiol. 75, 813–819 (1993)PubMed
21.
P. Möller, J. Bergström, P. Fürst, K. Hellström, Effect of aging on energy-rich phosphagens in human skeletal muscles. Clin. Sci. (Lond) 58, 553–555 (1980)
22.
S.A. Smith, S.J. Montain, R.P. Matott, G.P. Zientara, F.A. Jolesz, R.A. Fielding, Creatine supplementation and age influence muscle metabolism during exercise. J. Appl. Physiol. 85, 1349–1356 (1998)PubMed
23.
M.J. Chrusch, P.D. Chilibeck, K.E. Chad, K.S. Davison, D.G. Burke, Creatine supplementation combined with resistance training in older men. Med. Sci. Sports Exerc. 33, 2111–2117 (2001)PubMedCrossRef
24.
A. Brose, G. Parise, M.A. Tarnopolsky, Creatine supplementation enhances isometric strength and body composition improvements following strength exercise training in older adults. J. Gerontol. A Biol. Sci. Med. Sci. 58, 11–19 (2003)PubMedCrossRef
25.
M. Tarnopolsky, A. Zimmer, J. Paikin, A. Safdar, A. Aboud, E. Pearce, B. Roy, T. Doherty, Creatine monohydrate and conjugated linoleic acid improves strength and body composition following resistance exercise in older adults. PLoS ONE 2, 991 (2007)CrossRef
26.
D.G. Candow, J.P. Little, P.D. Chilibeck, S. Abeysekara, G.A. Zello, S. Kazachkov, S.M. Cornish, P.H. Yu, Low-dose creatine combined with protein during resistance training in older men. Med. Sci. Sports Exerc. 40, 1645–1652 (2008)PubMedCrossRef
27.
A.F. Aguiar, R.S. Januario, R.P. Junior, A.M. Gerage, F.L. Pina, M.A. do Nascimento, C.R. Padovani, E.S. Cyrino, Long-term creatine supplementation improves muscular performance during resistance training in older women. Eur. J. Appl. Physiol. 113, 987–996 (2013)PubMedCrossRef
28.
G. Parise, S. Mihic, D. MacLennan, K.E. Yarasheski, M.A. Tarnopolsky, Effects of acute creatine monohydrate supplementation on leucine kinetics and mixed-muscle protein synthesis. J. Appl. Physiol. 91, 1041–1047 (2001)PubMed
29.
R. Deminice, A.A. Jardao, Creatine supplementation reduces oxidative stress biomarkers after acute exercise in rats. Amino Acids 43, 709–715 (2011)PubMedCrossRef
30.
P. Sestili, C. Martinelli, E. Colombo, E. Barbieri, L. Potenza, S. Sartini, C. Fimognari, Creatine as an antioxidant. Amino Acids 40, 1385–1396 (2011)PubMedCrossRef
31.
A.P. Johnston, M. De Lisio, G. Parise, Resistance training, sarcopenia, and the mitochondrial theory of aging. Appl. Physiol. Nutr. Metab. 33, 191–199 (2008)PubMedCrossRef
32.
M.G. Bemben, M.S. Witten, J.M. Carter, K.A. Eliot, A.W. Knehans, D.A. Bemben, The effects of supplementation with creatine and protein on muscle strength following a traditional resistance training program in middle-aged and older men. J. Nutr. Health Aging 14, 155–159 (2010)PubMedCrossRef
33.
S. Bermon, P. Venembre, C. Sachet, S. Valour, C. Dolisi, Effects of creatine monohydrate ingestion in sedentary and weight-trained older adults. Acta Physiol. Scand. 164, 147–155 (1998)PubMedCrossRef
34.
B.O. Eijnde, M. Van Leemputte, M. Goris, V. Labarque, Y. Taes, P. Verbessem, L. Vanhees, M. Ramaekers, B. Vanden Eynde, R. Van Schuylenbergh, R. Dom, E.A. Richter, P. Hespel, Effects of creatine supplementation and exercise training on fitness in men 55–75-year-old. J. Appl. Physiol. 95, 818–828 (2003)PubMed
35.
K.A. Eliot, A.W. Knehans, D.A. Bemben, M.S. Witten, J. Carter, M.G. Bemben, The effects of creatine and whey protein supplementation on body composition in men aged 48 to 72 years during resistance training. J. Nutr. Health Aging 12, 208–212 (2008)PubMedCrossRef
36.
D.G. Candow, P.D. Chilibeck, Review: timing of creatine and protein supplementation during resistance training in the elderly. Appl. Physiol. Nutr. Metab. 33, 184–190 (2008)PubMedCrossRef
37.
M. Neves Jr, B. Guolano, H. Roschel, R. Fuller, F.B. Benatii, A.L. Pinto, F.R. Lima, R.M. Pereira, A.H. Lancha Jr, E. Bonfa, Beneficial effect of creatine supplementation in knee osteoarthritis. Med. Sci. Sports Exerc. 43, 1538–1543 (2011)PubMedCrossRef
38.
C.J. Hass, M.A. Collins, J.L. Juncos, Resistance training with creatine monohydrate improves upper-body strength in patients with Parkinson disease: a randomized trial. Neurorehabil. Neural Repair 21, 107–115 (2007)PubMedCrossRef
39.
S.J. Deacon, E.E. Vincent, P.L. Greenhaff, J. Fox, M.C. Steiner, S.J. Singh, M.D. Morgan, Randomized controlled trial of dietary creatine as an adjunct therapy to physical training in chronic obstructive pulmonary disease. Am. J. Respir. Care Med. 178, 233–239 (2008)CrossRef
40.
V.A. Cornelissen, J.G.M. Defoor, A. Stevens, D. Schepers, P. Hespel, M. Decramer, L. Mortelmans, F. Dobbels, J. Vanhaecke, R.H. Fagard, L. Vanhees, Effect of creatine supplementation as a potential adjuvant therapy to exercise training in cardiac patients: a randomized controlled trial. Clin. Rehabil. 24, 988–999 (2010)PubMedCrossRef
41.
D.G. Candow, P.D. Chilibeck, Potential of creatine supplementation for improving aging bone health. J. Nutr. Health Aging 14, 149–153 (2010)PubMedCrossRef
42.
M. Louis, J.R. Poortmans, M. Francaux, J. Berre, N. Boisseau, E. Brassine, D.J. Cuthbertson, K. Smith, J.A. Babraj, T. Waddell, M.J. Rennie, No effect of creatine supplementation on human myofibrillar and sarcoplasmic protein synthesis after resistance exercise. Am. J. Physiol. Endocrinol. Metab. 285, 1089–1094 (2003)
43.
M.A. Tarnopolsky, D.J. Mahoney, J. Vajsar, C. Rodriguez, T.J. Doherty, B.D. Roy, D. Biggar, Creatine monohydrate enhances strength and body composition in Duchenne muscular dystrophy. Neurology 62, 1771–1777 (2004)PubMedCrossRef
44.
P.D. Chilibeck, M.J. Chrusch, K.E. Chad, S.K. Davison, D.G. Burke, Creatine monohydrate and resistance training increase bone mineral content and density in older men. J. Nutr. Health Aging 9, 352–353 (2005)PubMed
45.
T.J. Beck, L.A. Kohlmeier, M.A. Petit, G. Wu, M.S. Leboff, J.A. Cauley, S. Nicholas, Z. Chen, Confounders in the association between exercise and femur bone in postmenopausal women. Med. Sci. Sports Exerc. 43, 80–89 (2011)PubMedCrossRef
46.
P.D. Chilibeck, J. Rooke, L. Paus-Jenssen, D. Candow, The effect of creatine monohydrate supplementation combined with resistance training on bone mineral density in older men and women. Appl. Physiol. Nutr. Metab. 37(S1), S6 (2012)
47.
A. Antolic, B.D. Roy, M.A. Tarnopolsky, R.F. Zernicke, G.R. Wohl, S.G. Shaughnessy, J.M. Bourgeois, Creatine monohyderate increases bone mineral density in young Sprague–Dawley rats. Med. Sci. Sports Exerc. 39, 816–820 (2007)PubMedCrossRef
48.
R.A. de Souza, M. Xavier, F.F. da Silva, M.T. de Souza, M.G. Tosato, A.A. Martin, J.C. Castilho, W. Ribeiro, L. Silveira Jr, Influence of creatine supplementation on bone quality in the ovariectomized rat model: an FT-Raman spectroscopy study. Lasers Med. Sci. 27, 487–495 (2012)PubMedCrossRef
49.
I. Gerber, I. ap Gwynn, M. Alini, T. Wallimann, Stimulatory effects of creatine on metabolic activity, differentiation and mineralization of primary osteoblast-like cells in monolayer and micromass cell cultures. Eur. Cell Mater. 10, 8–22 (2005)PubMed
50.
D.G. Burke, P.D. Chilibeck, G. Parise, D.G. Candow, D. Mahoney, M. Tarnopolsky, Effect of creatine and weight training on muscle creatine and performance in vegetarians. Med. Sci. Sports Exerc. 35, 1946–1955 (2003)PubMedCrossRef
51.
H. Yasuda, N. Shima, N. Nakagawa, S.I. Mochizuki, K. Yano, N. Fujise, Y. Sato, M. Goto, K. Yamaguchi, M. Kuriyama, T. Kanno, A. Murakami, E. Tsuda, T. Morinaga, K. Higashio, Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139, 1329–1337 (1998)PubMed
52.
S.M. Cornish, D.G. Candow, N.T. Jantz, P.D. Chilibeck, J.P. Little, S. Forbes, S. Abeysekara, G.A. Zello, Conjugated linoleic acid combined with creatine monohydrate and whey protein supplementation during strength training. Int J Sport Nutr Exerc. Metab. 19, 79–96 (2009)PubMed
53.
T.W. Buford, R.B. Kreider, J.R. Stout, M. Greenwood, B. Campbell, M. Spano, T. Ziegenfuss, H. Lopez, J. Landis, J. Antonio, International society of sport nutrition position stand: creatine supplementation and exercise. J. Int. Soc. Sports Nutr. 4, 6 (2007)PubMedCentralPubMedCrossRef
54.
H.J. Kim, C.K. Kim, A. Carpentier, J.R. Poortmans, Studies on the safety of creatine supplementation. Amino Acids 40, 1409–1418 (2011)PubMedCrossRef
55.
R. Jager, M. Purpura, A. Shao, T. Inoue, R.B. Kreider, Analysis of the efficacy, safety, and regulatory status of novel forms of creatine. Amino Acids 40, 1369–1383 (2011)PubMedCentralPubMedCrossRef
56.
Dietitians of Canada, American College of Sports Medicine, N.R. Rodriguez, N.M. Di Marco, S. Langley, American College of Sports Medicine position stand. Nutrition and athletic performance. Med. Sci. Sports Exerc. 41, 709–731 (2009)PubMedCrossRef
57.
T. Wallimann, M. Tokarska-Schlattner, U. Schlattner, The creatine kinase system and pleiotropic effects of creatine. Amino Acids 40, 1271–1296 (2011)PubMedCentralPubMedCrossRef
58.
J.R. Poortmans, A. Kumps, P. Duez, A. Fofonka, A. Carpentier, M. Francaux, Effect of oral creatine supplementation on urinary methylamine, formaldehyde, and formate. Med. Sci. Sports Exerc. 37, 1717–1720 (2005)PubMedCrossRef
59.
D.G. Burke, S. Silver, L.E. Holt, T. Smith Palmer, C.J. Culligan, P.D. Chilibeck, The effect of continuous low dose creatine supplementation on force, power, and total work. Int J Sport Nutr Exerc. Metab. 10, 235–244 (2000)PubMed
60.
T. Klopstock, M. Elstner, A. Bender, Creatine in mouse models of neurodegeneration and aging. Amino Acids 40, 1297–1303 (2011)PubMedCrossRef
61.
E.S. Rawson, A.C. Venezia, Use of creatine in the elderly and evidence for effects on cognition function in young and old. Amino Acids 40, 1349–1362 (2011)PubMedCrossRef
Metadaten
Titel
Creatine supplementation and aging musculoskeletal health
verfasst von
Darren G. Candow
Philip D. Chilibeck
Scott C. Forbes
Publikationsdatum
01.04.2014
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 3/2014
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-013-0070-4

Weitere Artikel der Ausgabe 3/2014

Endocrine 3/2014 Zur Ausgabe

Original Article

Changes in levels of peripheral hormones controlling appetite are inconsistent with hyperphagia in leptin-deficient subjects

Editorial

BRAF mutation assessment in papillary thyroid cancer: are we ready to use it in clinical practice?

Meta-Analysis

Prevalence of osteoporosis in prostate cancer survivors: a meta-analysis

Original Article

The exon 3 polymorphism of the growth hormone receptor is a severity-related factor for osteoporosis

Original Article

Association of the ATM gene polymorphisms with papillary thyroid cancer

Original Article

Incidental medullary thyroid microcarcinoma revealed by mild increase of preoperative serum calcitonin levels: therapeutic implications

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Bei Herzinsuffizienz muss „Eisenmangel“ neu definiert werden!

16.05.2024 Herzinsuffizienz Nachrichten

Bei chronischer Herzinsuffizienz macht es einem internationalen Expertenteam zufolge wenig Sinn, die Diagnose „Eisenmangel“ am Serumferritin festzumachen. Das Team schlägt vor, sich lieber an die Transferrinsättigung zu halten.

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise